The Bio21 Institute has strategic relationships with a range of industry tenants from the R&D group of Australia's largest biopharmaceutical company - CSL Limited, to diverse start-up companies residing in the Institute's Incubator and Business Centre.

Our industry tenants include:

• CSL Limited R&D group who are focused on therapeutic discovery
• BioScreen Medical who focus on microbial diagnostics
• Sienna Cancer Diagnostics who focus on molecular biomarkers for specific tumours
• Patrys Ltd is focused on natural human antibodies against human disease
• AT-Bio Pty Ltd who are developing small molecule western medicines for global markets

• Gene and NanoTechnology Information Service

Back to top